Epinoma

0 reviews

Epinoma is a biotechnology company specializing in epigenetic-driven diagnostics and therapeutics. Their flagship product, EpiAmp, is the first methyl-preserving amplification technology designed to unlock deep insights into the epigenome. By accurately preserving DNA methylation patterns during amplification, EpiAmp enhances the sensitivity and reliability of epigenetic analyses, enabling earlier disease detection and more precise monitoring. Key Features and Functionality: - Methyl-Preserving Amplification: EpiAmp maintains the integrity of DNA methylation during amplification, overcoming limitations of traditional methods that often degrade or alter these critical epigenetic marks. - Conversion-Free Process: Unlike conventional techniques that require chemical conversion, EpiAmp's approach minimizes sample degradation, resulting in higher sensitivity and more accurate data. - Rapid Turnaround: The streamlined workflow allows for single-day analysis, facilitating quicker decision-making in research and clinical settings. - Scalability: EpiAmp is designed for multiplex analysis at scale, enabling comprehensive examination of multiple loci of interest simultaneously. Primary Value and Solutions: EpiAmp addresses critical challenges in disease detection and monitoring by providing a robust tool for analyzing DNA methylation patterns. Its high sensitivity and accuracy allow for the early detection of diseases such as cancer and neurodegenerative disorders, potentially leading to improved patient outcomes. Additionally, EpiAmp's technology supports the development of precision epigenetic medicines by enabling targeted modulation of epigenetic sites, offering new therapeutic avenues without altering the underlying genomic sequences. For biopharmaceutical companies, EpiAmp facilitates the comparison of healthy and diseased epigenetic states, enhancing drug development processes and enabling more effective patient stratification strategies in clinical trials.